Reversible portal vein thrombosis complicating induction therapy of acute promyelocytic leukemia [1]

Thrombosis Research

Volumn 101, Issue 2, 2001, Pages 101-103

  Colovic, M ^a   MiljiC, P ^a   Colovic, N ^a   Jankovic, G ^a   Stojkovic, M ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTITHROMBIN III CONCENTRATE; CILASTATIN PLUS IMIPENEM; CYTARABINE; DOXORUBICIN; HEPARIN; PIPERACILLIN PLUS TAZOBACTAM; RETINOIC ACID; SOMATOSTATIN; STEROID; TEICOPLANIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HUMAN; LETTER; MALE; PNEUMONIA; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PORTAL VEIN; REMISSION INDUCTION; VENOUS THROMBOSIS;

EID: 0035862594     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00371-6     Document Type: Letter

References (6)

1. Early deaths and anti-haemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients
2. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid
3. All-trans retinoic acid: Not only a differentiation agent, but also an inducer of thromboembolic events in patients with M3 leukemia
4. Successful systemic thrombolysis of hepatic vein thrombosis in a patient with promyelocytic leukemia treated with all-trans retinoic acid
5. Acute promyelocytic leukemia. MD Anderson hospital experience
6. New insights into pathogenesis of coagulation dysfunction in acute promyelocytic leukemia